BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3596747)

  • 1. Time-course and extent of disturbance of the hepatic porphyrin pathway in hexachlorobenzene-exposed female rats.
    Koss G; Stoffelns B; Seubert S; Seubert A; Koransky W; Ippen H
    IARC Sci Publ; 1986; (77):493-5. PubMed ID: 3596747
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
    Elder GH; Urquhart AJ
    IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
    Smith AG; Francis JE
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental hepatic porphyria caused by hexachlorobenzene: mechanism of the metabolic block.
    De Matteis F
    IARC Sci Publ; 1986; (77):427-31. PubMed ID: 3596734
    [No Abstract]   [Full Text] [Related]  

  • 5. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
    Adjarov DG; Elder GH
    IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of N-acetylcysteine on the hexachlorobenzene induced porphyria in rats.
    Lissner R; Brunner W; Bolsen K; Merk H; Goerz G
    Arzneimittelforschung; 1985; 35(4):713-5. PubMed ID: 4015737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
    Alleman MA; Koster JF; Wilson JH; Edixhoven-Bosdijk A; Slee RG; Kroos MJ; von Eijk HG
    Biochem Pharmacol; 1985 Jan; 34(2):161-6. PubMed ID: 3966921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
    Franklin MR; Phillips JD; Kushner JP
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, iron status and sex factors of porphyria induced by hexachlorobenzene.
    Smith AG; Stewart FP; Francis JE
    IARC Sci Publ; 1986; (77):433-9. PubMed ID: 3596735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ethylenediaminetetracetic acid on hexachlorobenzene-induced changes in rats.
    Lambrecht RW; Ertürk E; Peters HA; Morris CR; Bryan GT
    IARC Sci Publ; 1986; (77):505-6. PubMed ID: 3110062
    [No Abstract]   [Full Text] [Related]  

  • 11. [Induction of experimental porphyria by hexachlorobenzene in rats].
    Enríquez de Salamanca R; Mas Andrés V; Catalán Beltrán T; Molina Ferragut C; Chinarro Familiar S; Olmos Andrés A
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):1-14. PubMed ID: 7100592
    [No Abstract]   [Full Text] [Related]  

  • 12. Continued depression of hepatic uroporphyrinogen decarboxylase activity caused by hexachlorobenzene or 2,3,7,8-tetrachlorodibenzo-p-dioxin despite regeneration after partial hepatectomy.
    Smith AG; Francis JE; Greig JB
    Biochem Pharmacol; 1985 May; 34(10):1817-20. PubMed ID: 4004897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
    Mylchreest E; Charbonneau M
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):23-33. PubMed ID: 9221820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic toxicity of hexachlorobenzene in the rat: clinical, biochemical, morphological and morphometric findings.
    Kuiper-Goodman T; Grant DL
    IARC Sci Publ; 1986; (77):343-6. PubMed ID: 3596724
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment.
    Koss G; Seubert S; Seubert A; Seidel J; Koransky W; Ippen H
    Arch Toxicol; 1983 Jan; 52(1):13-22. PubMed ID: 6838374
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of hexachlorobenzene porphyria in rats: time sequence and relationship with lipid peroxidation.
    Visser O; van den Berg JW; Edixhoven-Bosdijk A; Koole-Lesuis R; Rietveld T; Wilson JH
    Food Chem Toxicol; 1989 May; 27(5):317-21. PubMed ID: 2744662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyrins and pentachlorophenol in rat-liver mitochondria in hexachlorobenzene-induced porphyria.
    Trenti T; Ventura E; Ceccarelli D; Masini A
    IARC Sci Publ; 1986; (77):457-9. PubMed ID: 3596739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyrinogenic effect of hexachlorobenzene and 2,3,7,8-tetrachlorodibenzo-para-dioxin: is an inhibitor involved in uroporphyrinogen decarboxylase inactivation?
    Cantoni L; Graziani A; Rizzardini M; Saletti MC
    IARC Sci Publ; 1986; (77):449-56. PubMed ID: 3596737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hexachlorobenzene feeding and iron overload on enzymes of haem biosynthesis and cytochrome P 450 in rat liver.
    Louw M; Neethling AC; Percy VA; Carstens M; Shanley BC
    Clin Sci Mol Med; 1977 Aug; 53(2):111-5. PubMed ID: 891100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional derangement of liver mitochondria from hexachlorobenzene-treated rats.
    Trenti T; Ventura E; Ceccarelli D; Masini A
    IARC Sci Publ; 1986; (77):329-31. PubMed ID: 3596723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.